Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Active not recruiting 1

Sponsor Class

INDUSTRY 6OTHER 2NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Breast Neoplasms 4354Neoplasms 3056Prostatic Neoplasms 1904Colorectal Neoplasms 1739Lung Neoplasms 1555Carcinoma, Non-Small-Cell Lung 1270Pancreatic Neoplasms 981Leukemia, Myeloid, Acute 952Multiple Myeloma 951Lymphoma 912Head and Neck Neoplasms 894Leukemia 852Precursor Cell Lymphoblastic Leukemia-Lymphoma 833Neoplasm Metastasis 793Colonic Neoplasms 785Carcinoma, Hepatocellular 762Ovarian Neoplasms 757Melanoma 752Stomach Neoplasms 742Rectal Neoplasms 701Brain Neoplasms 696Lymphoma, Non-Hodgkin 663Leukemia, Lymphocytic, Chronic, B-Cell 618Uterine Cervical Neoplasms 607Lymphoma, Follicular 559Glioblastoma 541Recurrence 539Hodgkin Disease 532Esophageal Neoplasms 527Myelodysplastic Syndromes 508

Interventions

dalotuzumab 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × OTHER × Insulin-Like Growth Factor I, Resistance To × Clear all
NCT04767750 2022-04-07

Role of LncRNA H19 in The Regulation of IGF-1R Expression

Mansoura University

Completed
101 enrolled
Gastrointestinal

Insulin-Like Growth Factor I, Resistance To, Diabetes Mellitus, Type 2, Carcinoma, Hepatocellular, Neoplasms

NCT00799240 2014-11-07

IMPACT

University of Kansas Medical Center

Phase 2 Completed
27 enrolled
Thoracic

Insulin-Like Growth Factor I, Resistance To, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pleural Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡